Ready to start planning your care? Call us at 833-347-1665 to make an appointment.
Meet Medical Oncologist Anita Kumar
Meet Medical Oncologist Anita Kumar
Meet Medical Oncologist Anita Kumar
Anita Kumar is the Regional Care Network Medical Site Director at MSK Basking Ridge. Learn about how she cares for people with lymphoma, a type of blood cancer.
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
Medical Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
Internal Medicine; Medical Oncology; Hematology
I am a medical oncologist whose practice is devoted to caring for people with lymphoma. I have clinical expertise in the diagnosis and treatment of both Hodgkin and non-Hodgkin lymphoma and my research focus is on mantle cell lymphoma. I work closely with a team of lymphoma experts from many different departments. We are dedicated to providing personalized and compassionate care to our patients.
Read more
The lymphoma team’s mission is not only to provide the best care but also to push the envelope in terms of improving outcomes for our patients. I am grateful to be involved in clinical trials research aimed at improving treatments for patients with Hodgkin and non-Hodgkin lymphoma. Because of our innovative research program, we are able to deliver therapies that are not yet available anywhere else. Many of these treatments are less toxic and more effective than standard treatments. Currently, I am the principal investigator of clinical trials that incorporate novel biologically targeted therapies. These include ibrutinib (Imbruvica®), brentuximab vedotin (Adcetris®), lenalidomide (Revlimid®), and venetoclax (Venclexta™).
When people come to Memorial Sloan Kettering for their diagnosis and treatment, they benefit from the unparalleled experience and expertise of an entire group of people focused on their care. We regularly consult with one another to develop optimal treatment plans that align with our patients’ individual diagnoses, circumstances, and personal goals. As their doctor, I consider myself my patients’ advocate and guide throughout their entire journey, and I feel privileged and humbled to be a part of their lives.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Visit PubMed for a full listing of Dr. Kumar’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Anita Kumar discloses the following relationships and financial interests:
AstraZeneca Provision of Services
BridgeBio Inc. Ownership / Equity Interests
Janssen Oncology, Inc. Provision of Services
Kite Pharmaceuticals Provision of Services
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
